Directory
Every peptide, one record each
87 compounds across 15 classes. Each record carries mechanism, reported dosing, evidence level and regulatory status. Where a compound has no human trial data behind it, the record says so rather than burying it.
87 Compounds
16 FDA approved
63 Research use only
13 No human trials
Browse by class
Bioregulators 16 The Khavinson short peptide series, each associated with a specific tissue. Evidence comes largely from one research group. GHRPs & ghrelin mimetics 8 Agonists at the growth hormone secretagogue receptor, the target of endogenous ghrelin. Healing & repair 8 Compounds studied for soft tissue, gastrointestinal and wound repair. The highest-traffic and highest-scrutiny group. Nootropic & neuro 7 Peptides studied for cognition, anxiety, sleep and neuroprotection. GLP-1 & incretins 6 Incretin receptor agonists for glycaemic control and weight management, including the dual and triple agonists. IGF & growth factors 6 Insulin-like growth factor analogs, splice variants and growth hormone fragments. Cosmetic & topical 6 Topically applied peptides for skin ageing, pigmentation and expression lines. GHRH analogs 5 Growth-hormone-releasing hormone analogs that act on pituitary somatotrophs to stimulate endogenous GH release. Mitochondrial & longevity 5 Mitochondria-derived peptides and compounds targeting cellular ageing. Reproductive & HPTA 5 Compounds acting on the hypothalamic-pituitary-gonadal axis, including TRT adjuncts. Fat loss 4 Compounds targeting adipose tissue and energy metabolism outside the incretin pathway. Melanocortins 4 Melanocortin receptor agonists affecting pigmentation, appetite and sexual function. Myostatin inhibitors 3 Compounds that remove the myostatin brake on skeletal muscle growth. Thymic & immune 3 Thymus-derived peptides that modulate T-cell function and immune signalling. Other 1 Compounds that do not fall cleanly into the other classes.
All compounds
Showing all 87
| Compound | Class | Evidence | Reported range | Status |
|---|---|---|---|---|
| 5-Amino-1MQ Not a peptide | Fat loss | Animal models only | 50-150 mg | Research only |
| ACE-031 | Myostatin inhibitors | Clinical trials | 500 mcg - 3 mg | Research only |
| Adipotide | Fat loss | Animal models only | 500 mcg - 1 mg | Research only |
| AICAR Not a peptide | Fat loss | Clinical trials | 50-100 mg | Research only |
| Anamorelin Not a peptide | GHRPs & ghrelin mimetics | Clinical trials | 50-100 mg | Research only |
| AOD-9604 | Fat loss | Clinical trials | 300-600 mcg | Research only |
| ARA-290 | Healing & repair | Clinical trials | 2-4 mg | Research only |
| Argireline | Cosmetic & topical | Clinical trials | 5-10 mg | Unapproved |
| BPC-157 | Healing & repair | Animal models only | 200-500 mcg | Research only |
| Bronchogen Hub only | Bioregulators | Preliminary human | 100-200 mcg | Research only |
| Cagrilintide | GLP-1 & incretins | Clinical trials | 300 mcg - 2.4 mg | Research only |
| Cardiogen Hub only | Bioregulators | Preliminary human | 100-200 mcg | Research only |
| Cartalax Hub only | Bioregulators | Preliminary human | 100-200 mcg | Research only |
| Cerebrolysin | Nootropic & neuro | Clinical trials | 5-30 g | Research only |
| Chonluten Hub only | Bioregulators | Preliminary human | 100-200 mcg | Research only |
| CJC-1295 | GHRH analogs | Preliminary human | 100-300 mcg | Research only |
| CJC-1295 with DAC | GHRH analogs | Preliminary human | 1-2 mg | Research only |
| Cortagen Hub only | Bioregulators | Preliminary human | 100-200 mcg | Research only |
| Decapeptide-12 | Cosmetic & topical | Clinical trials | 1 mg | Unapproved |
| Dihexa | Nootropic & neuro | Animal models only | 8-45 mg | Research only |
| DSIP | Nootropic & neuro | Preliminary human | 100-300 mcg | Research only |
| Epitalon | Bioregulators | Preliminary human | 100-200 mcg | Research only |
| Follistatin-344 | Myostatin inhibitors | Animal models only | 100-300 mcg | Research only |
| FOXO4-DRI | Mitochondrial & longevity | Animal models only | 5-25 mg | Research only |
| GHK-Cu | Healing & repair | Clinical trials | 1-2 mg | Unapproved |
| GHRP-2 | GHRPs & ghrelin mimetics | Clinical trials | 100-300 mcg | Research only |
| GHRP-6 | GHRPs & ghrelin mimetics | Clinical trials | 100-300 mcg | Research only |
| Glutathione | Mitochondrial & longevity | Clinical trials | 200 mg - 2 g | Unapproved |
| Gonadorelin | Reproductive & HPTA | Regulator approved | 100-200 mcg | Approved |
| hCG Not a peptide | Reproductive & HPTA | Regulator approved | 250 mcg - 1.5 mg | Approved |
| Hexarelin | GHRPs & ghrelin mimetics | Clinical trials | 100-200 mcg | Research only |
| HGH Fragment 176-191 | IGF & growth factors | Preliminary human | 250-500 mcg | Research only |
| HMG Not a peptide | Reproductive & HPTA | Regulator approved | 75-150 mcg | Approved |
| Humanin Hub only | Mitochondrial & longevity | Animal models only | 1-5 mg | Research only |
| IGF-1 DES | IGF & growth factors | Animal models only | 50-150 mcg | Research only |
| IGF-1 LR3 | IGF & growth factors | Animal models only | 20-50 mcg | Research only |
| Ipamorelin | GHRPs & ghrelin mimetics | Preliminary human | 200-300 mcg | Research only |
| Kisspeptin-10 | Reproductive & HPTA | Clinical trials | 10-100 mcg | Research only |
| KPV | Healing & repair | Animal models only | 200-500 mcg | Research only |
| Lenomorelin Hub only | GHRPs & ghrelin mimetics | Clinical trials | 100-300 mcg | Research only |
| Liraglutide | GLP-1 & incretins | Regulator approved | 600 mcg - 3 mg | Approved |
| Livagen Hub only | Bioregulators | Preliminary human | 100-200 mcg | Research only |
| LL-37 | Healing & repair | Preliminary human | 100-500 mcg | Research only |
| Macimorelin | GHRPs & ghrelin mimetics | Regulator approved | 500 mg | Approved |
| Matrixyl | Cosmetic & topical | Clinical trials | 3-8 mg | Unapproved |
| Melanotan I | Melanocortins | Regulator approved | 500 mcg - 1 mg | Approved |
| Melanotan II | Melanocortins | Preliminary human | 250 mcg - 1 mg | Research only |
| MGF | IGF & growth factors | Animal models only | 100-200 mcg | Research only |
| MK-677 Not a peptide | GHRPs & ghrelin mimetics | Clinical trials | 10-25 mg | Research only |
| Mod GRF 1-29 | GHRH analogs | Preliminary human | 100-300 mcg | Research only |
| MOTS-c | Mitochondrial & longevity | Preliminary human | 5-10 mg | Research only |
| N-Acetyl Semax Amidate | Nootropic & neuro | Anecdotal only | 100-300 mcg | Research only |
| Ovagen Hub only | Bioregulators | Preliminary human | 100-200 mcg | Research only |
| P21 Hub only | Nootropic & neuro | Animal models only | 500 mcg - 1 mg | Research only |
| Palmitoyl Tetrapeptide-7 | Cosmetic & topical | Preliminary human | 1-4 mg | Unapproved |
| Pancragen Hub only | Bioregulators | Preliminary human | 100-200 mcg | Research only |
| PEG-MGF | IGF & growth factors | Animal models only | 200-400 mcg | Research only |
| Pentapeptide-18 | Cosmetic & topical | Preliminary human | 2-5 mg | Unapproved |
| Pentosan Polysulfate Not a peptide | Healing & repair | Regulator approved | 100-300 mg | Approved |
| Pinealon Hub only | Bioregulators | Preliminary human | 100-200 mcg | Research only |
| Prostamax Hub only | Bioregulators | Preliminary human | 100-200 mcg | Research only |
| PT-141 | Melanocortins | Regulator approved | 1-2 mg | Approved |
| PTD-DBM Hub only | Healing & repair | Animal models only | 1-2 mg | Research only |
| Retatrutide | GLP-1 & incretins | Clinical trials | 1-12 mg | Research only |
| Selank | Nootropic & neuro | Preliminary human | 250-750 mcg | Research only |
| Semaglutide | GLP-1 & incretins | Regulator approved | 250 mcg - 2.4 mg | Approved |
| Semax | Nootropic & neuro | Preliminary human | 300-900 mcg | Research only |
| Sermorelin | GHRH analogs | Regulator approved | 200-500 mcg | Approved |
| Setmelanotide | Melanocortins | Regulator approved | 1-3 mg | Approved |
| SNAP-8 | Cosmetic & topical | Preliminary human | 2-10 mg | Unapproved |
| Somatropin | IGF & growth factors | Regulator approved | 200 mcg - 1 mg | Approved |
| SS-31 | Mitochondrial & longevity | Clinical trials | 40-60 mg | Approved |
| Survodutide | GLP-1 & incretins | Clinical trials | 800 mcg - 6 mg | Research only |
| TB-500 | Healing & repair | Preliminary human | 2-5 mg | Research only |
| Tesamorelin | GHRH analogs | Regulator approved | 1-2 mg | Approved |
| Testagen Hub only | Bioregulators | Preliminary human | 100-200 mcg | Research only |
| Thymalin | Thymic & immune | Preliminary human | 10-20 mg | Research only |
| Thymogen | Bioregulators | Preliminary human | 100-200 mcg | Research only |
| Thymosin Alpha-1 | Thymic & immune | Clinical trials | 1.6-3.2 mg | Research only |
| Tirzepatide | GLP-1 & incretins | Regulator approved | 2.5-15 mg | Approved |
| Triptorelin | Reproductive & HPTA | Regulator approved | 100 mcg | Approved |
| Vesilute Hub only | Bioregulators | Preliminary human | 100-200 mcg | Research only |
| Vesugen Hub only | Bioregulators | Preliminary human | 100-200 mcg | Research only |
| Vilon Hub only | Bioregulators | Preliminary human | 100-200 mcg | Research only |
| VIP | Other | Clinical trials | 50-150 mcg | Research only |
| YK-11 Not a peptide | Myostatin inhibitors | In vitro only | 5-10 mg | Research only |
| Zn-Thymulin | Thymic & immune | Preliminary human | 100-200 mcg | Research only |
Sources
Regulatory and primary sources
- FDA: Bulk drug substances that may present significant safety risks (Category 2 and withdrawn nominations) ↗ · content current as of April 22, 2026; checked October 18, 2026
- FDA: Bulk drug substances used in compounding under section 503A ↗ · how the 503A categories work
- FDA: Unapproved drugs ↗ · status of products sold "for research use only"
- WADA Prohibited List ↗ · peptide hormones and growth factors, class S2
- PubMed (National Library of Medicine) ↗ · source of every literature reference on this site